首页|期刊导航|现代中西医结合杂志|基于心肌声学造影评价心衰Ⅰ号方对急性心肌梗死后心力衰竭患者冠脉微循环的影响

基于心肌声学造影评价心衰Ⅰ号方对急性心肌梗死后心力衰竭患者冠脉微循环的影响OA

Effect of Heart Failure No Ⅰ Decoction on coronary microcirculation in patients with heart failure after acute myocardial infarction based on evaluation of myocardial contrast echocardiography

中文摘要英文摘要

目的 基于心肌声学造影技术评估心衰Ⅰ号方对急性心肌梗死(AMI)后心力衰竭患者冠脉微循环障碍(CMD)的影响.方法 选取2021 年6 月—2023 年5 月在南京中医药大学附属医院(江苏省中医院)心内科治疗的 AMI 后心力衰竭合并 CMD 患者60 例,随机分为试验组和对照组各30 例.对照组给予常规西医治疗,试验组在对照组治疗基础上给予心衰Ⅰ号方治疗,2 组疗程均为8 周.比较2 组心肌灌注指数(MPSI)、室壁运动指数(WMSI)、灌注异常节段数、节段改善率、左室射血分数(LVEF)、左房内径(LAD)、左室舒张末内径(LVEDD)、左室收缩末内径(LVESD)、左室纵向总应变(LVGLS)、中医证候积分及中医证候疗效.结果 与治疗前比较,治疗后2 组 MPSI、LVESD 及试验组 WMSI、LAD、LVEDD 均明显降低(P 均<0.05),2 组灌注异常节段数均明显减少(P 均<0.05),2 组 LVEF、LVGLS 均明显升高(P 均<0.05);试验组 MPSI、WMSI、灌注异常节段数、LVEF 治疗前后差值及治疗后灌注异常节段改善率均明显高于对照组(P 均<0.05).治疗后2 组主症、次症、兼症、舌苔、脉象积分及总分均较治疗前明显降低(P 均<0.05),且试验组心悸、肢肿积分及总分治疗前后差值均明显高于对照组(P 均<0.05).试验组中医证候总有效率明显高于对照组[96.7%(29/30)比80.0%(24/30),P<0.05].结论 心衰Ⅰ号方可明显改善 AMI 后心力衰竭合并 CMD 患者左室收缩功能和 CMD,缓解心悸、肢肿等症状.

Objective It is to evaluate the effect of Heart Failure No Ⅰ Decoction on coronary microvascular dysfunc-tion(CMD)in patients with heart failure after acute myocardial infarction(AMI)based on myocardial contrast echocardio-graphy(MCE).Methods Sixty patients with heart failure and CMD after AMI treated at the Department of Cardiology of Jiangsu Provincial Hospital of Traditional Chinese Medicine from June 2021 to February 2023 were randomly divided into an experimental group and a control group,with 30 cases in each group.The control group was treated with conventional west-ern medicine,while the experimental group was treated with Heart Failure No Ⅰ Decoction based on the therapy in the control group,both groups were treated for 8 weeks.The following parameters were compared between the two groups:myo-cardial perfusion score index(MPSI),wall motion score index(WMSI),number of segments with abnormal perfusion,segmental improvement rate,left ventricular ejection fraction(LVEF),left atrial diameter(LAD),left ventricular end-di-astolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD),left ventricular global longitudinal strain(LVGLS),traditional Chinese medicine(TCM)syndrome scores,and TCM syndrome efficacy.Results Compared with those before treatment,the MPSI and LVESD in both groups,as well as WMSI,LAD and LVEDD in the experimental group were significantly reduced(all P<0.05),the numbers of segments with abnormal perfusion in both groups were sig-nificantly reduced(all P<0.05),and the LVEF and LVGLS in both groups were significantly increased(all P<0.05);the MPSI,WMSI,number of segments with abnormal perfusion,the difference value of LVEF before and after treatment,and the improvement rate of segments with abnormal perfusion after treatment in the experimental group were all significant-ly higher than those in the control group(all P<0.05).After treatment,the scores of primary symptoms,secondary symp-toms,accompanied symptoms,tongue picture and pulse,and total scores in both groups were significantly lower than those before treatment(all P<0.05),and the differences of scores of palpitations and limb edema and total scores before and af-ter treatment in the experimental group were significantly higher than those in the control group(all P<0.05).The overall response rate of TCM syndrome in the experimental group was significantly higher than that in the control group[96.7%(29/30)vs 80.0%(24/30),P<0.05].Conclusion Heart Failure No Ⅰ Decoction can significantly improve left ven-tricular systolic function and CMD,and alleviate symptoms such as palpitations and limb edema in patients with heart fail-ure with CMD after AMI.

湛武逸;王令谆;何安霞

南京中医药大学,江苏 南京 210023南京中医药大学附属医院(江苏省中医院),江苏 南京 210029南京中医药大学附属医院(江苏省中医院),江苏 南京 210029

医药卫生

心肌声学造影心衰Ⅰ号急性心肌梗死心力衰竭冠脉微循环障碍

myocardial contrast echocardiographyHeart Failure No Ⅰ Decoctionacute myocardial infarctionheart failurecoronary microvascular dysfunction

《现代中西医结合杂志》 2026 (15)

2082-2087,2097,7

江苏省中医药科技发展计划项目(YB2020007)江苏省中医院科技项目(Y2021ZR31)

10.3969/j.issn.1008-8849.2026.15.007

评论